162 related articles for article (PubMed ID: 21319316)
1. Fine-needle aspiration of renal cell carcinoma: is accurate Fuhrman grading possible on cytologic material?
Bishop JA; Hosler GA; Kulesza P; Erozan YS; Ali SZ
Diagn Cytopathol; 2011 Mar; 39(3):168-71. PubMed ID: 21319316
[TBL] [Abstract][Full Text] [Related]
2. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
[TBL] [Abstract][Full Text] [Related]
3. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of new schemes to group Fuhrman grades in clinical practice for clear cell renal tumour].
Morán E; Rogel R; Soto A; Ruiz-Cerdá JL; Budía A; Salom JV; Jiménez-Cruz JF
Actas Urol Esp; 2012 Jun; 36(6):352-8. PubMed ID: 22266258
[TBL] [Abstract][Full Text] [Related]
5. Cytohistological study of clear cell carcinoma of kidney with special reference to nuclear grading and tumor size.
Mondal SK
Diagn Cytopathol; 2012 Dec; 40(12):1083-7. PubMed ID: 21563327
[TBL] [Abstract][Full Text] [Related]
6. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
7. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
[TBL] [Abstract][Full Text] [Related]
8. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
[TBL] [Abstract][Full Text] [Related]
9. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
10. Utility of fine-needle aspiration and core biopsy with touch preparation in the diagnosis of renal lesions.
Scanga LR; Maygarden SJ
Cancer Cytopathol; 2014 Mar; 122(3):182-90. PubMed ID: 24353131
[TBL] [Abstract][Full Text] [Related]
11. World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grading in fine-needle aspiration biopsies of renal masses.
Perrino CM; Cramer HM; Chen S; Idrees MT; Wu HH
Diagn Cytopathol; 2018 Nov; 46(11):895-900. PubMed ID: 30488673
[TBL] [Abstract][Full Text] [Related]
12. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.
Bektas S; Bahadir B; Kandemir NO; Barut F; Gul AE; Ozdamar SO
Kaohsiung J Med Sci; 2009 Nov; 25(11):596-600. PubMed ID: 19858038
[TBL] [Abstract][Full Text] [Related]
13. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma?
Millet I; Curros F; Serre I; Taourel P; Thuret R
J Urol; 2012 Nov; 188(5):1690-4. PubMed ID: 22998910
[TBL] [Abstract][Full Text] [Related]
14. Successful grading of renal-cell carcinoma in fine-needle aspirates.
Al Nazer M; Mourad WA
Diagn Cytopathol; 2000 Apr; 22(4):223-6. PubMed ID: 10787141
[TBL] [Abstract][Full Text] [Related]
15. Prognostic ability of simplified nuclear grading of renal cell carcinoma.
Rioux-Leclercq N; Karakiewicz PI; Trinh QD; Ficarra V; Cindolo L; de la Taille A; Tostain J; Zigeuner R; Mejean A; Patard JJ
Cancer; 2007 Mar; 109(5):868-74. PubMed ID: 17262800
[TBL] [Abstract][Full Text] [Related]
16. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
Jeldres C; Sun M; Liberman D; Lughezzani G; de la Taille A; Tostain J; Valeri A; Cindolo L; Ficarra V; Artibani W; Zigeuner R; Mejean A; Descotes JL; Lechevallier E; Mulders PF; Perrotte P; Patard JJ; Karakiewicz PI
J Urol; 2009 Dec; 182(6):2585-9. PubMed ID: 19836799
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology.
Mathur S; Dawar R; Verma K
Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258
[TBL] [Abstract][Full Text] [Related]
18. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data.
Cajulis RS; Katz RL; Dekmezian R; el-Naggar A; Ro JY
Acta Cytol; 1993; 37(3):367-72. PubMed ID: 8498138
[TBL] [Abstract][Full Text] [Related]
19. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
